DBV Technologies S.A.
Biotechnology company · Chatillon, Île-de-France, France · Nasdaq: DBVT
DBV Technologies S.A. is a biotechnology company headquartered in Chatillon, Île-de-France, France. Its shares trade on Nasdaq under the ticker DBVT. It has reported private securities offerings to the US SEC, most recently $307 million sold in a notice filed in 2025.
DBV Technologies at a glance
What does DBV Technologies do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $306.9 million sold (2025).
Frequently asked questions about DBV Technologies
Where is DBV Technologies headquartered?
DBV Technologies S.A. is headquartered in Chatillon, Île-de-France, France.
What does DBV Technologies do?
DBV Technologies S.A. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is DBV Technologies a public company?
Yes. DBV Technologies S.A. trades on Nasdaq under the ticker DBVT.
Similar companies
- Innate Pharma SAMarseille, Provence-Alpes-Côte d'Azur, France
- Gensight Biologics S.A.Paris, Île-de-France, France
- PHAXIAM Therapeutics S.A.Lyon, Auvergne-Rhône-Alpes, France
- Cellectis S.A.Paris, Île-de-France, France
- Eyevensys S.A.S.Paris, Île-de-France, France
- Genfit S.A.Loos, Hauts-de-France, France
- Cerenis Therapeutics Holding S.A.Labège, Occitanie, France
- TheraclionMalakoff, Île-de-France, France
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences